VGE III Portfolio Ltd., 10% Owner at Urovant Sciences Ltd. (UROV), bought 14,485 shares at $7.68 ($110K) on 2019-05-28, disclosed to the SEC on 2019-05-29.
Scheduled purchase ($110k) by 10% Owner under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $7.70 | 3,796 | $29K | 26.5% |
| 2 | $7.68 | 3,807 | $29K | 26.5% |
| 3 | $7.55 | 6,882 | $52K | 47.1% |
| Total | $7.62 avg | 14,485 | $110K | 100% |
| Filing → |
| MYOV | BUY | 2018-04-04 | $45.0M | — | Filing → |